|
Name |
2-Pentadecanone
|
Molecular Formula | C15H30O | |
IUPAC Name* |
pentadecan-2-one
|
|
SMILES |
CCCCCCCCCCCCCC(=O)C
|
|
InChI |
InChI=1S/C15H30O/c1-3-4-5-6-7-8-9-10-11-12-13-14-15(2)16/h3-14H2,1-2H3
|
|
InChIKey |
CJPNOLIZCWDHJK-UHFFFAOYSA-N
|
|
Synonyms |
2-PENTADECANONE; Pentadecan-2-one; 2345-28-0; Methyl tridecyl ketone; Pentadecanone; FEMA No. 3724; CHEBI:89254; B2Q48J997N; UNII-B2Q48J997N; 2-Pentandecanone; EINECS 219-064-8; MFCD00053712; AI3-11706; SCHEMBL336157; 2-PENTADECANONE [FHFI]; 2-Pentadecanone, >=98.5%; CHEMBL3273567; DTXSID6062333; FEMA 3724; 2-Pentadecanone, >=98%, FG; CAA34528; ZINC1850860; 2-Pentadecanone, analytical standard; LMFA12000056; AKOS009157795; AS-56748; CS-0187603; FT-0613261; Pentadecanone; 95%; Methyl n-tridecyl ketone; D92066; A878236; J-015112; Q27161440; SSV
|
|
CAS | 2345-28-0 | |
PubChem CID | 61303 | |
ChEMBL ID | CHEMBL3273567 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 226.4 | ALogp: | 6.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 16 | QED Weighted: | 0.399 |
Caco-2 Permeability: | -4.7 | MDCK Permeability: | 0.00001250 |
Pgp-inhibitor: | 0.028 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.604 | Plasma Protein Binding (PPB): | 98.00% |
Volume Distribution (VD): | 1.627 | Fu: | 1.65% |
CYP1A2-inhibitor: | 0.498 | CYP1A2-substrate: | 0.245 |
CYP2C19-inhibitor: | 0.446 | CYP2C19-substrate: | 0.133 |
CYP2C9-inhibitor: | 0.202 | CYP2C9-substrate: | 0.953 |
CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.173 |
CYP3A4-inhibitor: | 0.18 | CYP3A4-substrate: | 0.067 |
Clearance (CL): | 4.262 | Half-life (T1/2): | 0.309 |
hERG Blockers: | 0.188 | Human Hepatotoxicity (H-HT): | 0.015 |
Drug-inuced Liver Injury (DILI): | 0.205 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.923 | Carcinogencity: | 0.053 |
Eye Corrosion: | 0.99 | Eye Irritation: | 0.931 |
Respiratory Toxicity: | 0.795 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000399 | 0.867 | D07ILQ | 0.615 | ||||
ENC000556 | 0.800 | D0Z5SM | 0.571 | ||||
ENC000378 | 0.800 | D05ATI | 0.559 | ||||
ENC000604 | 0.788 | D0O1PH | 0.521 | ||||
ENC000466 | 0.755 | D00AOJ | 0.455 | ||||
ENC000560 | 0.745 | D00FGR | 0.446 | ||||
ENC000422 | 0.735 | D0XN8C | 0.425 | ||||
ENC000265 | 0.733 | D0P1RL | 0.415 | ||||
ENC000495 | 0.731 | D0Z5BC | 0.397 | ||||
ENC000247 | 0.719 | D05QNO | 0.388 |